Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

DBCOND0132808Infections Skin and Subcutaneous Tissue Diseases

Acute Bacterial Skin and Skin Structure Infection (ABSSSI) is the indication for 6 drugs in DrugBank. It is covered by 10 curated, structured indications.

Also known as: acute bacterial skin and skin structure infections · Acute Bacterial Skin and Skin Structure Infection
Classified under: Infections
Skin and Subcutaneous Tissue Diseases
Indicated drugs: Ceftaroline fosamil
Dalbavancin
Delafloxacin
Omadacycline
Tedizolid
Tedizolid phosphate

Resolves to

Vocabularies

SNOMED CT128936008MedDRA10052891UMLSC0162627

What you can answer from here — as of October 22, 2026

6Indicated drugsWith each drug's targets and mechanism

Listed above

10Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

15Clinical trialsPhase, status and sponsor resolved per trial

4Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Acute Bacterial Skin and Skin Structure Infection (ABSSSI) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account